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Abstract. The major function of the venoms of the 
predatory marine snails belonging to the genus Conus is 
to paralyze prey. Thus, the venom of each Conus species 
acts on receptors and ion channels of the prey; previous 
studies suggested much less activity on homologous re-
ceptor targets in more distant taxa. In this article, we ad-
dress the question of whether some peptide components 
of Conus venoms ("conopeptides") have "cross-phylum" 
biological activity. 
We examined the venom of Conus textile, a mollusk-
hunting Conus, using a mammalian biological activity 
assay. We purified a 23 amino acid "convulsant peptide" 
with potent activity in the mammalian CNS, even though 
it comes from the venom of a snail-hunting Conus species. 
A survey of Conus textile venom fractions indicates that, 
in addition to the convulsant peptide, many other com-
ponents of this venom will exhibit "cross-phylum" bio-
logical activity. Conopeptides with broad-range phylo-
genetic specificity should be useful tools for studying the 
evolution of receptors and ion channels, and of nervous 
systems. 
Introduction 
The small peptides present in the venoms of the pred-
atory marine snails that belong to the genus Conus (cone 
snails) are proving to be of great interest in molecular 
neuroscience. This large and diverse family of highly con-
strained peptides ("conopeptides") are 10-30 amino acids 
in length and exhibit exquisite specificity towards cell sur-
face receptors and ion channels (for recent overviews see 
Olivera et al .. 1990, 1991). Some of the peptides are now 
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choice research tools in neurobiology. Because they are 
relatively rigid, their three-dimensional structures can be 
determined; the structures of several conopeptides have 
been solved by multidimensional NMR techniques. Given 
their small size and constrained conformation, the Conus 
peptides have great potential as lead compounds for drug 
development. 
In this introduction, we will briefly review the biology 
and biochemistry of conopeptides. Furthermore, we de-
scribe results on a peptide that has "cross-phylum" bio-
logical activity. Such conopeptides may be useful tools 
for examining how certain receptors and ion channels 
have been used by various phyla in the course of evolution. 
Biology and biochemistry of conopeptides 
The cone snails are believed to be the most venomous 
of all molluscs. Many human fatalities have been caused 
by cone snail envenomation. There are about 500 Conus 
species; all are predators, and all use venom as the primary 
means for subduing prey. The venom is injected into the 
prey with a hollow harpoon-like tooth. The species of 
Conus can be divided into three major groups on the basis 
of the animals they feed on, i.e., the worm-hunting, mol-
lusk-hunting and fish-hunting Conidae. The venom of at 
least one species of each of these groups has been analyzed. 
A major factor that contributes to the success of Conus 
is the remarkable biochemistry of their venoms. The bio-
logically active components of Conus venoms are an ex-
ceptionally diverse family of small, conformationally 
constrained peptides. A single Conus venom may well 
have over fifty different such peptides, with varied phar-
macological specificities. From the numerous peptides that 
have been purified from various Conus species, certain 
general concepts have emerged. 
Each natural conopeptide appears to be specifically tar-
geted to a macromolecular receptor, interfering with its 
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normal function. The conopeptides can have very high 
affinity for their receptors: w-conotoxin OVIA, for ex-
ample, targets to neuronal voltage-sensitive calcium 
channels and has sub-picomolar affinities for the high af-
finity targets. The high affinity and specificity of cono-
peptides is dependent on their highly constrained, rela-
tively rigid conformations. In the majority of conopep-
tides, Cys residues, which are involved in forming multiple 
disulfide bonds, constitute 20-50% of all amino acids (for 
an overview, see Olivera et al., 1990). 
Peptides in the size range of the conopeptides would 
not normally have a specific conformation, but would 
equilibrate between many alternative conformations un-
der physiological conditions. Usually, about 50 amino acid 
residues would be required before a polypeptide assumed 
a specific conformation. The sum of noncovalent forces 
(hydrogen bonds, hydrophobic interactions, and the like) 
in a small peptide are insufficient to stabilize a single con-
formation. But in most conopeptides the covalent cross-
linking through multiple disulfide bonding presumably 
stabilizes the biologically active conformation. Indeed, 
conopeptides have some of the highest known densities 
of disulfide bonding found in any biological system; one 
12 amino acid peptide isolated from a Conus venom has 
three disulfide bonds (see Olivera et al., 1990). 
A recent examination of cDNA clones encoding various 
conopeptides has revealed how the cone snails may have 
evolved the complex pharmacological cocktails of cono-
peptides that are their venoms. As will be described else-
where (D. R. Hillyard, unpub. results), an "antibody-like 
evolutionary strategy" probably generated the array of 
small Conus peptides with diverse ligand specificity, but 
relatively conserved folding pathways and structural 
frameworks. The net result is that every species has its 
own characteristic mixture of peptides, and this conopep-
tide cocktail is highly potent on the particular prey type 
on which the species specializes. Thus, not only has a 
rather unusual biochemical strategy been used for para-
lyzing prey (i.e., small, highly constrained peptides), but 
to generate the wide diversity of peptides in cone snail 
venom, a novel genetic and evolutionary strategy is em-
ployed by the genus as well. 
Phylogenetic specificity of conopeptides 
Pharmacological experiments carried out on crude 
venom by Endean and Rudkin (1963 and 1965) revealed 
that venom samples from Conus species that specifically 
prey on fish had no effect on mollusks or worms, and vice 
versa. These early studies suggested that the venom of a 
particular Conus species is presumably strongly selected 
to act on protein targets in the prey, and that the more 
unrelated the taxa to the prey, the more unlikely that it 
would have targets for the biologically active components 
in the venom. 
Studies of individually isolated conopeptides have sup-
ported this general picture of the phylogenetic specificity 
of Conus venoms. A conopeptide from the venom of a 
particular species is generally specific for targets in the 
phylum to which the prey belongs. The conopeptides from 
the fish-hunting Conus venoms have been particularly well 
studied. Although in all cases specifically tested, the pep-
tides have been inactive in invertebrate systems, they vary 
in how broadly they act. For example, a-conotoxins 01 
and MI from Conus geographus and magus, respectively, 
are broadly active in vertebrate systems, and appear to 
act at nicotinic acetylcholine receptors, not only in fish, 
but also in all mammalian systems tested. In contrast, a'-
conotoxin SI seems much more phylogenetically narrow 
in its biological activity: this peptide will inhibit nicotinic 
acetylcholine receptors in fish and in elasmobranchs 
(Torpedo), but its activity in mammalian systems is orders 
of magnitude less. Although the sequence changes are not 
very great, there are apparently strikingly different con-
formations assumed by these two peptides (Pardi et al., 
1990; Christensen et aI., 1991). The w-conotoxins and JL-
conotoxins, which target voltage-sensitive calcium chan-
nels and sodium channels, respectively, are also inactive 
in invertebrate systems. Considerable variation in the ac-
tivity of the w-conotoxins in different vertebrate systems 
has also been observed (see Ramilo et al., 1992). 
Thus, the general view of Conus venoms and conopep-
tides from studies on the fish-hunting species is that the 
agents to be found are likely to be vertebrate-specific. The 
studies on crude venoms suggest that worm-hunting spe-
cies are likely to have conopeptides specific to annelids, 
and snail-hunting cones are likely to have conopeptides 
that are mollusk-specific. The one invertebrate-specific 
peptide tested so far, the King-Kong (KK) peptide from 
the snail-hunting species, Conus textile, is inactive in 
mammalian systems (Hillyard et al., 1989). 
However, peptides with broad phylogenetic specifity 
are desirable as tools for investigating the role of their 
receptor targets over a long period of evolutionary time. 
The present evidence from cloning suggests that most re-
ceptors and ion channels evolved early in eukaryotic evo-
lution, and are widely used by all of the higher eukaryotic 
taxa. If a highly specific peptide ligand were able to inhibit 
the activity of such a receptor over a broad range of dif-
ferent phyla, the various uses to which that cell surface 
receptor had been put in the different taxa could be much 
more easily investigated. Thus, it is of interest to determine 
whether there are any conopeptides that have a broader 
specificity than those already characterized. In this article, 
we will show that a significant complement of conopep-
tides probably exhibit broad phylogenetic specificity. 
Materials and Methods 
Materials 
Specimens of Conus textile were collected from the sea 
around the islands of Marinduque, Philippines. Venom 
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was extracted from the specimens as described previously 
(Cruz et al .. 1976). 
Preparation of the venom extract 
About one gram of the lyophilized venom was sus-
pended in 10 ml of 1.1 % acetic acid, placed on ice for 10 
min with occasional stirring, then centrifuged at 12,000 
X g in a Sorvall refrigerated centrifuge. The residue was 
extracted twice with 5 ml 1.1 % acetic acid. Each time, the 
suspension was sonicated seven times at 65 watts (Sonifier, 
Heat Systems Ultrasonics, Inc.) for 10 sat 15-s intervals 
before centrifugation. The supernates were pooled and 
lyophilized. 
Gel filtration chromatography 
Lyophilized venom extract was dissolved in 5 ml of 
1.1 % acetic acid. The dissolved extract was chromato-
graphed at 4°C on a column (110 X 2.5 cm) of Sephadex 
G-25 (fine), with 1.1 % HAc as the eluent. The fractions 
corresponding to the chromatographic peaks were pooled, 
lyophilized, bioassayed, and stored at -20°C for further 
separation by HPLC. 
High performance liquid chromatography 
The lyophilized Sephadex G-25 fraction was redissolved 
in 2.0 ml of 0.1 % tritluoroacetic acid (TFA), filtered, then 
chromatographed in several batches on a semi-preparative 
CI8 column (TSK-ODS 120T, 7.8 X 300 mm, fully 
capped, 10 ~m particle size). Subsequent fractionations 
were done on an analytical VYDAC reverse-phase C I8 
column (4.6 X 250 mm, 5 ~m) and a Brownlee Spheri-5 
ODS column (4.6 X 220 mm, 5 ~m). The solvent system 
used for all HPLC runs consisted of 0.1 % TFA as buffer 
A, and 0.1 % TF A in 60% acetonitrile as buffer B. 
Amino acid analysis 
Peptide samples were hydrolyzed in vacuo with 6 N 
HCL/I% phenol for 18 h at 105°C. Amino acid analysis 
was done by reverse-phase HPLC of phenylthiocarbamyl 
derivatives (Bidlingmeyer et al.. 1984; Heinrikson and 
Meredith, 1984). 
Peptide sequencing 
The purified convulsant peptide was reduced and car-
boxymethylated as previously described (Cruz et al .. 1987) 
and then analyzed in a spinning-cup sequencer according 
to the method ofTarr et al. (1978). Phenylthiohydantoin 
derivatives were identified by HPLC using a gradient 
slightly modified from that of Hunkapiller and Hood 
(1978). 
Results 
Assay ofa venom from a snail-hunting Conus species 
for mammalian activity 
To examine whether components of a particular Conus 
venom are restricted in their activity to the phylum of its 
prey, we investigated the biological activities present in 
the venom of Conus textile. Conus textile is a common 
molluscivorous cone, and is one of the more highly suc-
cessful large species in the genus. It is widely distributed 
from the Hawaiian Islands to the Red Sea, and is abundant 
in much of the Indo-Pacific. This species is of particular 
interest because it has been reported to be fatal to humans. 
However, when the venom was initially examined by En-
dean and Rudkin (1963), they did not find that it was 
active when tested in vertebrate systems. 
We decided to re-examine the activity of Conus textile 
venom components for activity on mammalian receptors. 
Our laboratory has developed a sensitive assay for con-
opeptides that display activity in mammals. Direct injec-
tion of a venom component into the central nervous sys-
tem of mice (i.c. injection) has proven to be an effective 
method for identifying vertebrate-active components (see 
Olivera et al.. 1990). The components of Conus textile 
venom were therefore assayed by i.c. injection into mice. 
In this assay, both crude Conus textile venom, and all 
crude fractions assayed, had potent activity when injected 
intra-cranially into mice. Crude Conus textile venom 
causes seizure-like symptoms and death in mice. To de-
termine the identity of a vertebrate-active component of 
the venom, we purified and characterized one venom 
component using biological activity in the mouse CNS as 
an assay. 
Purification and characterization of a convulsant peptide 
from Conus textile venom 
Conus textile venom was first fractionated according 
to size, as shown in Figure IA. A major peptide fraction 
was then subfractionated by reverse-phase HPLC as shown 
in Figure I B. The earliest eluting fraction from the first 
HPLC column caused paralysis and death in mice. This 
fraction was then rerun on reverse-phase HPLC. Two 
fractions in Figure I C characteristically caused sudden 
jumping activity shortly after injection, and this was fol-
lowed by convulsions, stretching of limbs, and jerking 
behavior. After these initial symptoms, the mouse would 
lie on its side and after approximately 25 min would tend 
to recover from the most severe symptoms. This general 
type of behavior was elicited by more than one peak in 
the chromatogram in Figure I C, but only the indicated 
peak was further purified to homogeneity. Further HPLC 
purification finally yielded a homogeneous peptide with 
a convulsant activity (Fig. I D). There may be, however, 
several isoforrns of the convulsant peptide in Conus textile 
venom; this is being further investigated. 
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Figure l. Purification of a convulsant peptide from Conus textile 
venom. Details of the procedure are described in Materials and Methods. 
(A) Column chromatography of crude venom extract on Sephadex G-
25 with 1.1 % acetic acid as eluent. (B) HPLC of pooled fractions from 
the shaded peak of Panel A on semi-preparative reversed phase C 18 
column at a gradient of 1.2% CH3CN/min in 0.1% TFA. (C) The peak 
indicated by an arrow in B was further fractionated by HPLC on an 
analytical CI8 column at 0.6% CH3CN/min in 0.1% TFA. The peak 
corresponding to the convulsant peptide is indicated by an arrow. This 
was rerun on HPLC to remove impurities. (D) HPLC of purified con-
vulsant peptide on a Brownlee CI8 column using a 0.6% CH3CN/min 
gradient in 0.1% TFA (23.8 min corresponds to 29.3% CH3CN). The 
peaks indicated by numbers in panel B produced the following behavioral 
effects when injected intracranially in two-week old mice: (I) twitching, 
jerking, and paralysis; (2) jerking and stretching; (3) hyperactivity followed 
by weakness; (4) circular motion and jerking; (5) jumping, jerking, and 
running; (6) scratching and hyperactivity; (7) jumping and circular mo-
tion; (8) stretching; and (9) running and rolling over. Peaks I, 3, 5, 6 
and 9 are lethal. 
The purified peptide was then subjected to amino acid 
analysis, as well as Edman sequencing. The results of these 
analyses are shown in Table I. The data are consistent 
with the convulsant peptide being a 23 amino acid peptide 
with the sequence: 
NCPYCVVYCCPPA YCEASGCRPP. 
To confirm the sequence and to determine whether the 
peptide was blocked at the carboxyl terminus, a fast atom 
bombardment (FAB) mass spectrometric analysis was 
carried out. The observed mass value of the convulsant 
peptide was 2487.90 mass units. The calculated value, if 
the peptide were amidated at the C-terminus, is 2487.95. 
These data therefore confirm the peptide sequence given 
Table I 
Determination of the primary slruc/llre of the convulsant peptide 
A. Amino acid analysis 
Amino acid* prool Mole ratio** 
Asp 57.9 0.7 (I) 
Glu 149.9 1.9 (1) 
Ser 87.1 1.1 (1) 
Gly 107.3 1.3 (1) 
Arg 83.5 1.0 (1) 
Ala 137.7 1.7 (2) 
Pro 390.6 4.9 (5) 
Tyr 126.5 1.6 (3) 
Val 71.9 0.9 (2) 
Cys 153.5 1.9 (6) 
B. Sequence analysis 
Yield 






















Molecular weight: MH+ = 2487.90 






















Calc. MW = 2487.95 
* Cys residues were analyzed as the carboxymethyl adduct. 
** Values in parenthesis indicate the number of amino acid residues 
found by sequence analysis as verified by FAB mass spectrometry. 
The first step yielded a significant amount of glutamic acid as a con-
taminant. No residues were assigned for residues 22 and 23 since the 
yields for these steps were very low. 
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Table II 











, I, I 
CKSEGSS<[SfTSYNCCRSrNEYTKRCY • 
(CC---C---C---CC) 
I I I I 
RDCCTPPKKCKDRQCKPQRCCA* 




P hydroxyproline; * denotes an amidated C-terminus. 
above, and suggest that the convulsant peptide is amidated 
at the C-terminus, as is common among conopeptides. 
Multiple peptides active in mammalian systems from 
Conus textile venom 
During the purification of the convulsant peptide, we 
found that many other fractions exhibited activity in the 
mammalian central nervous system. Thus, the fractions 
from the first HPLC step were assayed for activity by the 
mouse i.e. injection assay. Many of the fractions (indicated 
by numbers in Fig. 1 B) induce dramatic and diverse 
symptomatology in mice, and some fractions are lethal. 
Although the proportion of active fractions may be sig-
nificantly lower than in a fish-hunting Conus venom, a 
very significant proportion of the total that were assayed 
still showed biological activity in the mammalian CNS. 
These results indicate that many components of Conus 
textile venom have potent activity on receptors present 
in the mammalian central nervous system. Since the one 
component that was purified and characterized was a typ-
ical disulfide-rich conopeptide, we think it likely that 
Conus venoms will yield many such peptides with cross-
phylum biological activity. 
Discussion 
The convulsant peptide described above has a number 
of interesting pharmacological and structural features. It 
defines a new subclass of conopeptides. As we have de-
scribed previously, although the peptides in Conus venoms 
exhibit remarkable pharmacological diversity, the cysteine 
framework of these peptides is, in fact, highly conserved. 
Three major conopeptide classes of disulfide frameworks 
have been characterized so far, i.e., the 2-100p, 3-100p, 
and 4-100p structural frameworks, as indicated in Table 
II (see Olivera et al., 1990, 1991). The convulsant peptide 
clearly belongs to the class of conopeptides with four-loop 
structural frameworks. 
But, within each structural framework class, rather dis-
tinctive subclasses emerge. For the four-loop conotoxin 
frameworks in particular, two distinctive subclasses were 
previously characterized; they are designated as Group I 
(the w-conotoxin subclass) and Group II (the KK peptide 
subclass) in Table III. These subclasses are distinguishable 
by the overall biochemical characteristics oftheir peptides; 
in the case of the w-conotoxins, the amino acids are over-
whelmingly hydrophilic, and the peptides have a high net 
positive charge. In the case of the KK peptides, the in-
tercysteine amino acids are considerably more hydropho-
bic, with a net negative charge. 
The convulsant peptide differs from these two classes 
in having a very different number of amino acids present 
in each of the four amino acid loops between Cys residues. 
Between the first and second cysteine residues, and the 
second and third Cys, both the King-Kong peptides and 
the w-conotoxins have 5-6 amino acids; in the convulsant 
peptide, the first two loops are extremely short with only 
two and three amino acids, respectively. A peptide with 
the same length distribution as the convulsant peptide 
has also been found in a worm-hunting cone, Conus quer-
cinus (Abogadie et at.. 1990). The convulsant peptide and 
this latter conopeptide will probably define a new subclass 
within the four-loop structural framework class, distinct 
from either the KK peptide or the w-conotoxin subclasses. 
We are especially interested in determining the prepro-
peptide structure of the convulsant peptide. The prepro 
regions of the KK conopeptides and the w-conotoxins have 
recently been found to be homologous but clearly diver-
gent from each other (Colledge and Hillyard, 1992; D. 
Hillyard, unpub. results). In contrast, all KK peptides are 
highly homologous in the sequences of the prepro regions 
of the precursor molecule. If, as we postulate, the con-
vulsant peptide defines a new subclass of four-loop con-
opeptides, we expect that the prepro sequences will exhibit 
some homology, but also considerable divergence from 
the KK and w-conotoxin subclasses of precursors. It 
should then become possible to quickly identify other 
Table III 
Four-loop conopeptides: proposed subclasses 
Name Charge 
Group I 
w-Conotoxin GVIA CKSEGSSCSETSYNCCRSCNEYTKRCY* +5 
w-Conotoxin MVIIA CKGKGAKCSRLMYDCCTGSCRSGKC * +6 
Group II 
KK-O peptide WCKQSGEMCNLLDQNCCDGYCIVLVCT-2 
KK-l peptide CIEQFDPCEMIRHTCCVGVCFLMACI-1.5 
Group III 
Convulsant peptide NCPYCVVYCCPPAYCEASGCRPP' +1 
The w-conotoxins were described in Olivera et al., 1985; the KK pep-
tides in Woodward et al., 1990. p stands for hydroxyproline; * means 
that the peptide is amidated at the C-terminus. 
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members of the convulsant peptide subclass by a molec-
ular genetic approach; probes specific for the prepro re-
gions should permit the facile identification of new con-
opeptides that are structurally within the convulsant pep-
tide subclass. 
The potent activity of this peptide in mammalian sys-
tems might not have been predicted from earlier data on 
crude venoms and well-characterized conopeptides from 
fish-hunting cone snails. Because the convulsant peptide 
is found in the venom of Conus textile. which clearly spe-
cializes in hunting other gastropod mollusks, finding a 
conopeptide that is highly potent in the mammalian cen-
tral nervous system raises a number of interesting ques-
tions. Are there some biological reasons why Conus textile 
might have evolved a peptide that is active in mammalian 
systems? We think it more likely that the peptide has a 
receptor target that is highly conserved in both mammals 
and mollusks, and that this peptide will prove to have a 
particularly broad phylogenetic range. 
The experiments described above provide a paradigm 
for quickly identifying a subset of peptides in a Conus 
venom that are likely to have a broad phylogenetic range, 
i.e .. assaying for biological activity in a phylum totally 
unrelated to the prey. Such peptides are probably not un-
common. In the preliminary survey of a Conus textile 
venom fraction shown in Figure 1 B, we found a very sig-
nificant proportion of all components in the venom active 
when injected into the central nervous system of mam-
mals. The convulsant peptide is thus only the first of many 
such cross-phylum peptides to be characterized in detail. 
It will be of interest to determine whether the subset 
of receptors targeted by such "broad-range" conopeptides 
is different from the subset of receptors targeted by narrow 
range conopeptides. However, further investigation into 
these issues will require the identification of the molecular 
targets of the convulsant peptide and other broad range 
conopeptides. We believe that the availability of "broad-
range" conopeptides will be important in elucidating, not 
only the evolution of various ion channels and receptors, 
but ultimately the evolution of nervous systems in higher 
eukaryotes. 
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